BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.8%)
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner KKR Genetic Disorder L.P.
BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%), etc.
BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(13.4%),O. Andreas Halvorsen(13.4%), etc.
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas
BridgeBio Pharma | 3: Initial statement of beneficial ownership of securities-Officer Trimarchi Thomas
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Scott Randal W.
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Satvat Ali J.
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director MOMTAZEE JAMES C
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Hassan Fred
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Ellis Andrea
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director MCCORMICK FRANK
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Lo Andrew
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director HOMCY CHARLES J
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director DANIELS RONALD J
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Dachille Douglas A.
No Data
No Data